Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verastem
Biotech
Verastem bags options on GenFleet RAS programs to grow pipeline
One month into the job, Paterson has put together a financial package worth up to $625.5 million to bag options on three GenFleet programs.
Nick Paul Taylor
Aug 28, 2023 10:30am
Verastem takes on debt to get RAS tumor program to finish line
Mar 28, 2022 8:30am
Verastem CMO quits 2 weeks into the job
Jan 20, 2021 9:50am
Verastem pens KRAS-focused drug licensing deal with Chugai
Jan 8, 2020 9:20am
Mylan CEO Bresch to exit company after merger—Chutes & Ladders
Aug 2, 2019 9:30am
Verastem signs on Brian as CEO
Jul 30, 2019 10:03am
